BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

  November 18, 2024

   · 

  3 min read
• Press Releases

  Cancer Targeted Technology Receives Fast Track $2.4M Grant to Develop an Innovative PSMA-Targeted Small Molecule Drug Conjugate for Prostate Cancer

  November 18, 2024

   · 

  2 min read
• Press Releases

  REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

  November 18, 2024

   · 

  15 min read
• Press Releases

  Press Release: Sequana Medical Announces Strong 24-Month Results from POSEIDON Study at AASLD The Liver Meeting® in San Diego; US PMA alfapump approval expected before end of Q1 2025

  November 18, 2024

   · 

  10 min read
• Press Releases

  Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE

  November 18, 2024

   · 

  6 min read
• Press Releases

  BioCryst Launches ORLADEYO® (berotralstat) in Ireland

  November 18, 2024

   · 

  5 min read
• Press Releases

  AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer

  November 18, 2024

   · 

  13 min read
• Press Releases

  UK Regulator MHRA Grants Nanomerics Clinical Trials Authorisation Notice for its Upcoming OC134 Clinical Trial

  November 18, 2024

   · 

  2 min read
• Press Releases

  Atopic Dermatitis Clinical Trials Market Size to Hit USD 7.07 Bn by 2033

  November 18, 2024

   · 

  1 min read
• Press Releases

  Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome

  November 18, 2024

   · 

  7 min read